Australian govt Action Agenda for pharma

3 June 2001

The Australian government has set up an Action Agenda for thepharmaceutical industry, which Senator Nick Minchin, Minister for Industry, Science and Resources, says is "an exciting opportunity to create a long-term vision for the industry in Australia." A leaders' group, chaired by Institute of Drug Technology head Graeme Blackman, will develop the Agenda by identifying strategic industry issues and recommending actions to address them.

Australian Pharmaceutical Manufacturers Association chief executive Alan Evans welcomed the move as "an absolute necessity if we are to continue to have a viable industry in Australia." Much work has already been done by the Productivity Commission to highlight the differences in drug prices between Australia and the USA and Australia and Europe, he said, adding: "the industry is keen to build on this by working in partnership with governments to make sure that the Australian industry survives well into the future."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight